Results 21 to 30 of about 23,951 (282)

Evaluation of the Safety and Feasibility of Apheresis in Dogs: For Application in Metastatic Cancer Research

Animals, 2021
In patients with solid tumors, circulating tumor cells (CTCs) spread in their blood and function as a seed for metastases. However, the study of CTCs has been limited by their rarity, low frequency, and heterogeneity.
Haru Yamamoto, Mohamed Elbadawy, Koudai Fujisaka, Yomogi Sato, Takahiro Ohmori, Yuta Shinohara, Yui Hatano, Daichi Kobayashi, Ayana Gomyo, Yuji Sudo, Daigo Azakami, Tsuyoshi Uchide, Ryuji Fukushima, Shohei Morita, Amira Abugomaa, Hideyuki Yamawaki, Masahiro Kaneda, Tatsuya Usui, Kazuaki Sasaki   +18 more
doaj   +1 more source

International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report

, 2023
Therapeutic apheresis is an extracorporeal treatment that selectively removes abnormal cells or harmful substances in the blood that are associated with or cause certain diseases.
Ulaş, Turgay, Turgut, Burhan, Başçı, Semih, Ozatli, Duzgun, Giden, A.O., Özatlı, D., Giden, Asli Odabasi, Erkurt, Mehmet Ali, Karakuş, Abdullah, Özatlı, Düzgün, Giden, Aslı Odabaşı, Korkmaz, S., Turgut, B., Ulaş, T., Korkmaz, Serdal, Başçı, S., Erkurt, M.A., Basci, Semih   +17 more
core   +1 more source

Retrospective Evaluation of Dual Specialty Ports in Therapeutic Apheresis. [PDF]

J Clin Apher
ABSTRACT Dual specialty ports were evaluated for safety and efficacy in therapeutic apheresis by analyzing outcomes across 97 port placement events in 88 patients, focusing on two configurations: dual Bard PowerFlow (BP2) and a combination of Bard PowerFlow with AngioDynamics SmartPort (BP + AD).
Swar-Eldahab M, Obeng-Gyasi B, Haste P, Krosin M.   +3 more
europepmc   +2 more sources

Smooth Muscle–Selective Nuclear Factor‐κB Inhibition Reduces Phosphate‐Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundHyperphosphatemia is a major factor promoting the formation of arterial medial calcification in chronic kidney disease (CKD). However, arterial medial calcification begins to occur during the early stages of CKD, when hyperphosphatemia is not ...
Tadashi Yoshida, Maho Yamashita, Chihiro Horimai, Matsuhiko Hayashi   +3 more
doaj   +1 more source

Therapeutic Plasma Exchange: A Cross-sectional Study from a Tertiary Care Centre, Srinagar, India [PDF]

National Journal of Laboratory Medicine, 2023
Introduction: Therapeutic Plasma Exchange (TPE) is a procedure in which blood is passed extracorporeally through an automated cell separator which separates plasma from cellular components of blood.
Rubiya Ryhan, Rumana Hamid Makdoomi, Hilal Ahmad Tali   +2 more
doaj   +1 more source

Does plateletpheresis induce a hypercoagulable state? A global assessment of donor’s hemostatic system by ROTEM

Platelets, 2019
Since there is still debate on the effects of plateletpheresis on coagulation system, we aimed to perform a global assessment of donor’s hemostatic function undergoing plateletpheresis by rotation thromboelastometry (ROTEM) analysis and to clarify if ...
O. Meltem Akay, Fatih Taştekin, Ertuğrul Çolak   +2 more
doaj   +1 more source

Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis

Journal of Lipid Research, 2012
High LDL-cholesterol (LDL-C) characterizes familial hypercholesterolemia (FH) and familial combined hyperlipidemia (FCH). LDL-apheresis, used in these patients to reduce LDL-C levels, has been shown to also affect HDL levels and composition.
M.P. Adorni, F. Zimetti, M. Puntoni, F. Bigazzi, F. Sbrana, F. Minichilli, F. Bernini, N. Ronda, E. Favari, T. Sampietro   +9 more
doaj   +1 more source

LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection

Journal of Lipid Research, 2011
Subnormal HDL-cholesterol (HDL-C) and apolipoprotein (apo)AI levels are characteristic of familial hypercholesterolemia (FH), reflecting perturbed intravascular metabolism with compositional anomalies in HDL particles, including apoE enrichment. Does LDL-
Alexina Orsoni, Samir Saheb, Johannes H.M. Levels, Geesje Dallinga-Thie, Marielle Atassi, Randa Bittar, Paul Robillard, Eric Bruckert, Anatol Kontush, Alain Carrié, M. John Chapman   +10 more
doaj   +1 more source

Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System. [PDF]

J Clin Apher
In this study we analyzed 12 years of adverse events, (AE) data from the World Apheresis Association, (WAA) Registry specific to the Spectra Optia Apheresis System.
Haubner A, Mendoza S, Vrielink H, Witt V, Deeren D, Bojanic I, Gasova Z, Aandahl A, Glatt TN, Vasilache AM, Newman E, Strineholm V, Skosana Y, Stegmayr B.   +13 more
europepmc   +2 more sources

H.E.L.P. LDL-apheresis clinical experience in Italy

, 2011
H.E.L.P. LDL-apheresis clinical experience in ItalyStefanutti Claudia, Shafii Mahnaz, Di Giacomo Serafina, Morozzi Claudia, Mazzilli Sara and the Italian Multicenter Study on Low-Density-Lipoprotein -Apheresis Working GroupExtracorporeal Therapeutic ...
MOROZZI, CLAUDIA, STEFANUTTI, Claudia, M. Shafii, DI GIACOMO, SERAFINA, The Italian Multicenter Study O. N. Low Density Lipoprotein Apheresis Working Group, S. Mazzilli   +5 more
core   +1 more source